Mometasone furoate (MF) improves lung function in pediatric asthma: A double‐blind, randomized controlled dose‐ranging trial of MF metered‐dose inhaler

Summary Objectives Mometasone furoate (MF), delivered via dry‐powder inhaler (DPI) QD in the evening (PM), is a treatment option for pediatric patients with asthma. We evaluated MF delivered via a metered‐dose inhaler (MDI), in children ages 5–11 years with persistent asthma. Methods This was a 12‐w...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatric pulmonology 2017-03, Vol.52 (3), p.310-318
Hauptverfasser:	Amar, Niran J., Shekar, Tulin, Varnell, Tracey A., Mehta, Anish, Philip, George
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Inflammatory Agents - administration & dosage Asthma - drug therapy Asthma - physiopathology Child Child, Preschool Dose-Response Relationship, Drug Double-Blind Method Female Forced Expiratory Volume - physiology Humans inhaled corticosteroids Least-Squares Analysis Male Metered Dose Inhalers mometasone furoate Mometasone Furoate - administration & dosage pediatric asthma
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!